Phosphorylation of serine/threonine residues in Eph receptors can trigger ligand-independent signalings, as exemplified by S897-phosphorylated EphA2, which activates AKT and PI3K, promoting the migration and invasion of cancer cells. The gene discussed is EPHA2; the disease is cancer.